[ATX] YoY Quarter Result on 30-Sep-2022 [#Q2]

Stock
[ATX] Amplia Therapeutics Limited
Announcement Date
29-Sep-2022
Financial Year
2023
Quarter
30-Sep-2022 [#Q2]
Profit Trend
QoQ- -25.41%
YoY- -120.11%
Quarter Report
ATX's Result
ATX's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 1,407 2,448 1,769 763 860 0 51 73.74%
PBT -2,814 -3,578 -4,640 -2,085 -1,371 -885 -718 25.53%
Tax 0 -2,448 -1,728 -763 -860 -0 0 -
NP -2,814 -1,129 -2,912 -1,323 -511 -885 -718 25.53%
Tax Rate - - - - - - - -
Total Cost 4,221 3,578 4,681 2,085 1,371 885 769 32.78%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin -200.02 -46.12 -164.57 -173.45 -59.45 0.00 -1,410.33 -27.76%
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -0.01 -0.01 -0.01 -0.01 -0.01 -0.02 -0.02 -10.90%
EPS Diluted -0.01 -0.01 -0.01 -0.01 -0.01 -0.02 -0.02 -10.90%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.